Lipoprotein(a) ning yurak-qon tomir kasalliklarining rivojlanishidagi ahamiyati Raushan E.Jemuratova ,Aleksandr B. Shek (Muallif) 152-158 2025-06-30
Lipidlar almashinuvi va gipolipidemik terapiyaning zamonaviy yondashuvlari Malika U.Yaxyoeva,Rano B.Alieva,Aleksandr B.Shek (Muallif) 75-91 2026-03-30
PAI-1 4G/5G genetik polimorfizmining yurak ishemik kasalligi rivojlanishidagi ahamiyati Rano A. Kurbanova,Aleksandr B. Shek,Andrey R. Kim (Muallif) 247-254 2024-12-30
Epikardial yog' qatlami yurak-qon tomir kasalliklarida prognostik belgi sifatida Andrey R.Kim ,Nigora Z.Srojidinova ,Aleksandr B.Shek ,Хurshid G.Fozilov (Muallif) 69-76 2024-03-30
Koronar arteriya kasalligi va kardiometabolik buzilishlarga ega bo'lgan bemorlarning xavfini baholashda epikardial yog' qatlami qalinligi Andrey R.Kim ,Rano B.Aliyeva ,Aleksandr B.Shek ,Shokhista S.Akhmedova,Liliya E.Kan (Muallif) 132-142 2024-06-30
Ateroskleoz patogenezida mikrornklarning roli: tadqiqotlarda yangi ufqlar Dilnora B.Yusupalieva ,Ulugbek I.Nizamov ,Rano B.Alieva ,Shokhista S.Akhmedova,Aleksandr B.Shek (Muallif) 43-50 2024-03-30
Lokal yog’ depolarning ishemik yurak kasalligi patogenezidagi o'rni: tana massa indeksidan tashqari Dilnora B.Yusupaliyeva ,Rano B.Aliyeva ,Shoxista S.Axmedova ,Aleksandr B.Shek (Muallif) 248-263 2025-09-30
Metabolik sindromli yurak ishemik kasalligi (YIK) bo‘lgan bemorlarda epikardial yog‘ qatlami qalinligi dinamikasiga kombinatsiyalangan patogenetik terapiyaning ta’siri Andrey R.Kim,Aleksandr B.Shek ,Rano B.Alieva (Muallif) 202-211 2025-09-30
Trigliseridlar/yuqori zichlikdagi lipoproteinlar indeksining yurak-qon tomir hodisalarining prediktor sifatida ahamiyatiа A.R. Kim,R.B. Aliyeva,A.B. Shek (Muallif) 29-38 2025-03-30
Aterogenezda CD36 skavenjer-retseptorining o‘rni: molekulyar mexanizmlar va terapevtik istiqbollar Dilnora Yusupalieva,R.B.Aliyeva,Sh.Musabayeva,U.I.Nizamov,Sh.S.Axmedova,A.B.Shek (Muallif) 97-110 2026-09-02